Oragenics Inc
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002 for the treatment of mild traumatic brain injury, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to redu… Read more
Market Cap & Net Worth: Oragenics Inc (OGEN)
Oragenics Inc (NYSE MKT:OGEN) has a market capitalization of $3.25 Million ($3.25 Million) as of March 19, 2026. Listed on the NYSE MKT stock exchange, this USA-based company holds position #33331 globally and #10888 in its home market, demonstrating a -18.77% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Oragenics Inc's stock price $0.78 by its total outstanding shares 4168223 (4.17 Million).
Oragenics Inc Market Cap History: 2015 to 2026
Oragenics Inc's market capitalization history from 2015 to 2026. Data shows change from $3.75 Billion to $3.25 Million (-48.88% CAGR).
Oragenics Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Oragenics Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
622.84x
Oragenics Inc's market cap is 622.84 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.75 Billion | $1.18 Million | -$11.71 Million | 3189.97x | N/A |
| 2021 | $111.54 Million | $86.99K | -$15.71 Million | 1282.28x | N/A |
| 2022 | $26.28 Million | $131.52K | -$14.29 Million | 199.85x | N/A |
| 2023 | $23.45 Million | $37.65K | -$20.66 Million | 622.84x | N/A |
Competitor Companies of OGEN by Market Capitalization
Companies near Oragenics Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Oragenics Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Oragenics Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Oragenics Inc's market cap moved from $3.75 Billion to $ 3.25 Million, with a yearly change of -48.88%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.25 Million | 0.00% |
| 2025 | $3.25 Million | +111.21% |
| 2024 | $1.54 Million | -93.44% |
| 2023 | $23.45 Million | -10.78% |
| 2022 | $26.28 Million | -76.43% |
| 2021 | $111.54 Million | -0.67% |
| 2020 | $112.29 Million | -14.15% |
| 2019 | $130.80 Million | -39.10% |
| 2018 | $214.78 Million | -63.44% |
| 2017 | $587.47 Million | -56.50% |
| 2016 | $1.35 Billion | -64.00% |
| 2015 | $3.75 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Oragenics Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.25 Million USD |
| MoneyControl | $3.25 Million USD |
| MarketWatch | $3.25 Million USD |
| marketcap.company | $3.25 Million USD |
| Reuters | $3.25 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.